Publications by authors named "Fe Bosch"

Claim this Profile
L
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials.
Kenneth B Gordon, Andrew Blauvelt, Hervé Bachelez, Laura C Coates, Filip E Van den Bosch

Dermatol Ther (Heidelb)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASAS consensus definition of early axial spondyloarthritis.
Victoria Navarro-Compán, Diego Benavent, Dafne Capelusnik, Désirée van der Heijde, Robert Bm Landewé, Filip E Van den Bosch

Ann Rheum Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update.
Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, Daniel Aletaha, Xenofon Baraliakos, Filip E Van den Bosch

Ann Rheum Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature.
Désirée van der Heijde, Anna Molto, Sofia Ramiro, Jürgen Braun, Maxime Dougados, Filip E Van den Bosch

Ann Rheum Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis.
Alen Zabotti, Gabriele De Marco, Laure Gossec, Xenofon Baraliakos, Daniel Aletaha, Filip E Van den Bosch

Ann Rheum Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to: 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial'' by Cai and Peng.
Anna Molto, Désirée van der Heijde, Filip E Van den Bosch, Maxime Dougados

Ann Rheum Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study.
Robert B M Landewé, Denis Poddubnyy, Proton Rahman, Filip E Van den Bosch, Rebecca Bolce

Ann Rheum Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update.
Sofia Ramiro, Elena Nikiphorou, Alexandre Sepriano, Augusta Ortolan, Casper Webers, Filip E Van den Bosch

Ann Rheum Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the design of RCTs in non-radiographic axial spondyloarthritis.
Walter P Maksymowych, Robert G W Lambert, Liron Caplan, Filip E van den Bosch, Mikkel Østergaard

Nat Rev Rheumatol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to: 'Finding the right one' by Zanwar.
Thomas Renson, Filip E Van den Bosch, Dirk Elewaut

Ann Rheum Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected impact of COVID-19 lockdown on spinal mobility and health perception in spondyloarthritis.
Sophie De Mits, Ann-Sophie De Craemer, Liselotte Deroo, Thomas Renson, Filip E Van den Bosch

Ann Rheum Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial.
Anna Molto, Clementina López-Medina, Filip E Van den Bosch, Annelies Boonen, Casper Webers

Ann Rheum Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study.
Philip J Mease, Apinya Lertratanakul, Kim A Papp, Filip E van den Bosch, Shigeyoshi Tsuji

Rheumatol Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis.
Roy M Fleischmann, Ricardo Blanco, Stephen Hall, Glen T D Thomson, Filip E Van den Bosch

Ann Rheum Dis· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axial involvement in patients with early peripheral spondyloarthritis: a prospective MRI study of sacroiliac joints and spine.
Thomas Renson, Philippe Carron, Ann-Sophie De Craemer, Liselotte Deroo, Manouk de Hooge, Filip E Van den Bosch

Ann Rheum Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High prevalence of spondyloarthritis-like MRI lesions in postpartum women: a prospective analysis in relation to maternal, child and birth characteristics.
Thomas Renson, Anaïs Depicker, Ann-Sophie De Craemer, Liselotte Deroo, Gaëlle Varkas, Filip E Van den Bosch

Ann Rheum Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction.
Robert Bm Landewé, Désirée van der Heijde, Maxime Dougados, Xenofon Baraliakos, Filip E Van den Bosch

Ann Rheum Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoscintigraphy in axial spondyloarthritis: a new imaging modality for sacroiliac inflammation.
Philippe Carron, Thomas Renson, Manouk de Hooge, Bieke Lambert, Kathia De Man, Filip E Van den Bosch

Ann Rheum Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, Maarten de Wit, Iain McInnes, Filip E Van den Bosch

Ann Rheum Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis.
Uta Kiltz, Robert B M Landewé, Désirée van der Heijde, Martin Rudwaleit, Michael H Weisman, Filip E Van den Bosch

Ann Rheum Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group.
Walter P Maksymowych, Robert Gw Lambert, Mikkel Østergaard, Susanne Juhl Pedersen, Pedro M Machado, Filip E Van den Bosch

Ann Rheum Dis· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to: 'Use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?' by Wu .
Lennart Jans, Isabelle De Kock, Nele Herregods, Koenraad L Verstraete, Filip E Van den Bosch

Ann Rheum Dis· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis.
Uta Kiltz, Désirée van der Heijde, Annelies Boonen, Nurullah Akkoc, Wilson Bautista-Molano, Filip E Van den Bosch

Ann Rheum Dis· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA study.
Santiago Rodrigues Manica, Alexandre Sepriano, Sofia Ramiro, Fernando Pimentel Santos, Polina Putrik, Filip E van den Bosch

Ann Rheum Dis· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA study.
Elena Nikiphorou, Désirée van der Heijde, Sam Norton, Robert Bm Landewé, Anna Molto, Filip E Van den Bosch

Ann Rheum Dis· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis